Agendia, a world leader in molecular cancer diagnostics, today announced MammaPrint(R)'s ability to predict opposition to neoadjuvant chemotherapy in breast cancer. ÂLatest Medical News From Around The World
For breast cancer survivors, the idea of taking estrogen pills is almost a taboo. In fact, their doctors give them drugs to get rid of the hormone because it can fuel the growth of breast cancer.

More: - Brought to my attention by